15-48201415-A-G

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001145668.2(CTXN2):ā€‹c.115A>Gā€‹(p.Ile39Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000362 in 1,551,418 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.00020 ( 0 hom., cov: 32)
Exomes š‘“: 0.00038 ( 0 hom. )

Consequence

CTXN2
NM_001145668.2 missense

Scores

2
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.18
Variant links:
Genes affected
CTXN2 (HGNC:31109): (cortexin 2) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
SLC12A1 (HGNC:10910): (solute carrier family 12 member 1) This gene encodes a kidney-specific sodium-potassium-chloride cotransporter that is expressed on the luminal membrane of renal epithelial cells of the thick ascending limb of Henle's loop and the macula densa. It plays a key role in concentrating urine and accounts for most of the NaCl resorption. It is sensitive to such diuretics as furosemide and bumetanide. Some Bartter-like syndromes result from defects in this gene. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional splice variants have been described but their biological validity in humans has not been experimentally proven.[provided by RefSeq, May 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.014050335).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CTXN2NM_001145668.2 linkuse as main transcriptc.115A>G p.Ile39Val missense_variant 2/2 ENST00000417307.3 NP_001139140.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CTXN2ENST00000417307.3 linkuse as main transcriptc.115A>G p.Ile39Val missense_variant 2/21 NM_001145668.2 ENSP00000406145 P1
ENST00000559875.1 linkuse as main transcriptn.270T>C non_coding_transcript_exon_variant 1/22

Frequencies

GnomAD3 genomes
AF:
0.000204
AC:
31
AN:
152188
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000338
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000228
AC:
35
AN:
153802
Hom.:
0
AF XY:
0.000159
AC XY:
13
AN XY:
81602
show subpopulations
Gnomad AFR exome
AF:
0.000126
Gnomad AMR exome
AF:
0.000405
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000404
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000379
AC:
530
AN:
1399114
Hom.:
0
Cov.:
31
AF XY:
0.000361
AC XY:
249
AN XY:
690080
show subpopulations
Gnomad4 AFR exome
AF:
0.0000633
Gnomad4 AMR exome
AF:
0.000448
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000203
Gnomad4 NFE exome
AF:
0.000454
Gnomad4 OTH exome
AF:
0.000362
GnomAD4 genome
AF:
0.000204
AC:
31
AN:
152304
Hom.:
0
Cov.:
32
AF XY:
0.000228
AC XY:
17
AN XY:
74468
show subpopulations
Gnomad4 AFR
AF:
0.000120
Gnomad4 AMR
AF:
0.000196
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000338
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000131
Hom.:
0
Bravo
AF:
0.000178
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ExAC
AF:
0.0000922
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJan 23, 2023The c.115A>G (p.I39V) alteration is located in exon 2 (coding exon 1) of the CTXN2 gene. This alteration results from a A to G substitution at nucleotide position 115, causing the isoleucine (I) at amino acid position 39 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.058
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
18
DANN
Benign
0.87
DEOGEN2
Benign
0.0055
T;T;T;T
Eigen
Benign
-0.30
Eigen_PC
Benign
-0.13
FATHMM_MKL
Benign
0.72
D
LIST_S2
Uncertain
0.87
.;.;.;D
M_CAP
Benign
0.0028
T
MetaRNN
Benign
0.014
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationTaster
Benign
0.89
D;D
PrimateAI
Uncertain
0.63
T
PROVEAN
Benign
-0.37
.;.;N;.
REVEL
Benign
0.058
Sift
Benign
0.64
.;.;T;.
Sift4G
Benign
0.85
.;.;T;.
Polyphen
0.0
B;B;B;B
Vest4
0.093
MVP
0.44
ClinPred
0.046
T
GERP RS
3.5
Varity_R
0.040
gMVP
0.71

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs547332844; hg19: chr15-48493612; API